Abstract
In recent years, there has been speculation about the possibility of a reduction in the incidence of fractures after liver transplantation (LT) because of changes in the characteristics of candidates and the use of different immunosuppressive therapies. We analyzed the characteristics of LT candidates (CTC) and compared them with historical data from a group of LT candidate patients (HTC). Data from 60 CTC patients consecutively included in a screening program of metabolic bone disease were compared with data from 60 HTC patients prospectively evaluated between 1992 and 1993. In all patients, we analyzed the clinical and laboratory characteristics, bone mineral density (BMD) dual-energy X-ray absorptiometry, and skeletal fractures. Patients in the CTC group were older than patients in the HTC group. The CTC group had lower femoral neck T scores. No differences were observed between groups in the proportion of patients with osteoporosis (22 vs. 30 %, p = ns) or fractures (36 vs. 33 %, p = ns). The percentage of patients with normal BMD decreased from 38 to 20 %. 25(OH)D values were low in both groups. Only 7.5 % of the CTC patients received calcium and/or vitamin D supplementation. The prevalence of fractures among CTC patients was similar to that seen two decades ago. At present, candidates for LT are older and have lower femoral bone mass. Vitamin D deficiency remains frequent; however, calcium and/or vitamin D supplementation is uncommon.
Similar content being viewed by others
References
McDonald JA, Dunstan CR, Dilworth P et al (1991) Bone loss after liver transplantation. Hepatology 14:613–619
Meys E, Fontanges E, Fourcade N, Thomasson A, Pouyet M, Delmas PD (1994) Bone loss after orthotopic liver transplantation. Am J Med 97:445–450
Porayko MIK, Wiesner RH, Hay YE et al (1991) Bone disease in liver transplant recipients: incidence, timing, and risk factors. Transplant Proc 23:1462–1465
Navasa N, Monegal A, Guañabens N et al (1994) Bone fractures in liver transplant patients. Br J Rheumatol 33:52–55
Monegal A, Navasa M, Guañabens N et al (2001) Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos Int 12:484–492
Ninkovik M, Skingle SJ, Bearcroft PW, Bishop N, Alexander GJ, Compston JE (2000) Incidence of vertebral fractures in the first three months after orthotopic liver transplantation. Eur J Gastroenterol Hepatol 12:931–935
Eastell R, Dickson ER, Hodgson SF et al (1991) Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 14:296–300
Vedi S, Greer S, Skingle SJ et al (1999) Mechanism of bone loss after liver transplantation: a histomorphometric analysis. J Bone Miner Res 14:281–287
Bjøro K, Brandsaeter B, Wiencke K et al (2003) Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease. Scand J Gastroenterol 38:320–327
Martinez G, Gómez R, Jódar E, Loinaz C, Moreno E, Hawkins E (2002) Long-term follow-up of bone mass after orthotopic liver transplantation: effect of steroid withdrawal from the immunosuppressive regimen. Osteoporos Int 13:147–150
Segal E, Baruch Y, Kramsky R, Raz B, Tamir A, Ish-Shalom S (2003) Predominant factors associated with bone loss in liver transplant patients after prolonged post-transplantation period. Clin Transplant 17:13–19
Guichelaar MM, Kendall R, Malinchoc M, Hay JE (2006) Bone mineral density before and after OLT: long-term follow-up and predictive factors. Liver Transpl 12:1390–1402
Premaor MO, Das TK, Debiram I et al (2011) Fracture incidence after liver transplantation: results of a 10 year audit. QJM 104:599–606. doi:10.1093/qjmed/hcr025
Guadalix S, Martínez-Díaz-Guerra G, Lora D et al (2011) Effect of early risedronate treatment on bone mineral density and bone turnover markers after liver transplantation: a prospective single-center study. Transpl Int 24:657–665
Wagner D, Amrein K, Dimai HP et al (2012) Ibandronate and calcitriol reduces fracture risk, reverse bone loss, and normalizes bone turnover after ITX. Transplantation 93:331–336
Monegal A, Guañabens N, Suárez MJ et al (2009) Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial. Transpl Int 22:198–206
Monegal A, Navasa M, Guañabens N et al (1997) Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 60:148–154
Dawson-Hughes BN, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (2005) Estimates of optimal vitamin D status. Osteoporos Int 16:713–716
Wibaux C, Legroux-Gerot I, Dharancy S et al (2011) Assessing bone status in patients awaiting liver transplantation. Joint Bone Spine 78:387–391
Dolgos S, Hartmann A, Isaksen GA et al (2010) Osteoporosis is a prevalent finding in patients with solid organ failure awaiting transplantation—a population based study. Clin Transplant 24:E145–E152
Lin JC, Hsieh TY, Wu CC, Chen PJ, Chueh TH, Chang WK, Chu HC (2012) Association between chronic hepatitis C virus infection and bone mineral density. Calcif Tissue Int 91:423–429
Mitchelli R, McDermid J, Ma MM, Chik CL (2011) Meld score, insulin-like growth factor 1 and cytokines on bone density in end-stage liver disease. World J Hepatol 3:157–163
Acknowledgments
The authors acknowledge Ana Dura (Liver Transplant Office secretary) and Eva López (Liver Transplant Office nurse) for their support in the study.
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors have stated that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Monegal, A., Navasa, M., Peris, P. et al. Bone Disease in Patients Awaiting Liver Transplantation. Has the Situation Improved in the Last Two Decades?. Calcif Tissue Int 93, 571–576 (2013). https://doi.org/10.1007/s00223-013-9797-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-013-9797-4